Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Spironolactone in Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

NCT01021943 is registered in ClinicalTrials.gov with Instituto Nacional de Cardiologia Ignacio Chavez as lead sponsor.

NCT NCT01021943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01021943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Spironolactone in Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients
Lead sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Phase
Phase 2
Overall status
Suspended
Start date
November 30, 2009
Completion date
Not reported
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant